Baseline thrombopoietin level is associated with platelet count improvement in thrombocytopenic chronic hepatitis C patients after successful direct-acting antiviral agent therapy

BACKGROUND: Thrombocytopenia can rapidly improve in chronic hepatitis C (CHC) patients receiving direct-acting antiviral agents (DAA). The role of baseline (BL) thrombopoietin (TPO) in this phenomenon is unclear. METHODS: From June 2016 to February 2019, a total of 104 CHC patients receiving DAA, wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yen-Chun, Ko, Ping-Hung, Lee, Chi-Che, Tseng, Chih-Wei, Tseng, Kuo-Chih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818549/
https://www.ncbi.nlm.nih.gov/pubmed/33478399
http://dx.doi.org/10.1186/s12876-021-01606-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818549/
https://www.ncbi.nlm.nih.gov/pubmed/33478399
http://dx.doi.org/10.1186/s12876-021-01606-x

Ejemplares similares